The WHO’s Initiative for Vaccine Research (IVR) released its Strategic Plan 2010-2020. The Executive Summary of the 34-page plan notes:
“Building on a decade of experience, IVR has formulated a long-term Strategic Plan that takes account of the evolving vaccine R&D landscape, and of the strong leadership role it can play as the WHO integrated vaccine research arm. The much welcomed new players in the vaccine R&D pipeline accentuate the need for increased global coordination and normative and technical support to countries, roles that are at the heart of IVR’s mandate.
“The Strategic Plan 2010–2020 has a matrix approach that uses four strategic functions and a set of priority areas to address public health priorities, and it is here that IVR has most significantly evolved since the previous strategy. The matrix is directly aligned with WHO’s corporate strategy and policies to stimulate innovation in health research, as well as with the global immunization agenda of the Organization. This harmonization will further strengthen synergies between research- and disease-focused programmes.
Strategic functions
The four strategic functions that will guide the core work of IVR over the next 10 years are:
i) identification of vaccine and vaccination research priorities;
ii) the development of research standards and guidelines;
iii) the strengthening of research and product development capacity;
iv) the translation of research results into policy and practice.
vaccines and global health :: ethics and policy 